FAYETTEVILLE, Ark. - TelAve -- Lineus Medical is pleased to announce a new distribution agreement with DIMA MedTech, marking the company's entry into the Italian market and further expanding its growing presence across Europe after receiving CE mark in December of 2025. Through this agreement, DIMA MedTech will provide Lineus Medical with a local presence in Italy as well as support the introduction and expansion of SafeBreak Vascular throughout Italy.

SafeBreak Vascular is the only breakaway device for IV lines clinically proven to reduce multiple IV complications.¹ When a harmful force is placed on an IV line, SafeBreak intentionally separates to remove the damaging force from the IV line and protect the patient's vascular access. Upon separation, valves on both ends of the device close, preventing medicine spills from the pump and blood loss from the patient. The separated device causes the IV pump to alarm, notifying the nursing staff to check on the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile device is installed, and the patient's infusion is continued. SafeBreak Vascular is cleared for all vascular lines down to two weeks of age– delivering better outcomes for patients, efficiency for nurses, and cost savings for hospitals alike.¹

More on TelAve News

• FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP)
• Autonomous Robotics Platform Expansion as Public Market Debut is Very Close: MBody AI Corp. (N A S D A Q: MBAI)
• Loud! OOH calls for prize draw advertising standards as £1.3bn category moves outdoors
• Black Ribbon Productions Launches With Fearless 2026 Horror Slate
• Actor Dominic Pace Returns to Television and Film

Larry Hayes, Lineus Medical's Chief Commercial Officer, stated, "This agreement marks another significant milestone in Lineus Medical's international growth. By partnering with DIMA MedTech, we are beginning our commercialization strategy in Europe and continuing to build momentum for broader global adoption. DIMA MedTech's local expertise and established network make them the right partner to drive commercial success throughout Italy."

Vance Clement, CEO of Lineus Medical, stated, "Expanding into Italy is a meaningful step forward in our mission to remove the "pains" associated with medical lines. First came European regulatory clearance for our product, and next is the establishment of a robust European distribution network. DIMA MedTech is a terrific distributor in Italy and our first in Europe."

About Lineus Medical

Lineus Medical develops innovative medical technologies designed to improve patient safety and healthcare efficiency. Its flagship product, SafeBreak Vascular, is a breakaway device for IV lines that helps protect patients from accidental IV dislodgements and associated complications.¹

More on TelAve News

• Opteamix welcomes Girish Ramachandra to its leadership team as Senior Vice President of Client Services
• Silicon Box Ships 500M Units at High Yield, Expands Production Capacity for Panel-Level Packaging
• Why Baton Rouge's Humid Climate Can Contribute to Carpenter Ant Damage — J&J Exterminating Explains How to Protect Your Home
• RPR Promotes Emily Line to Chief Strategy Officer and Janine Sieja to Chief Product Officer
• Expanding Beyond Space as New Drone Market Opportunities Accelerate Growth: Ascent Solar Technologies (N A S D A Q: ASTI)

About DIMA MedTech

DIMA MedTech is an operational partner for international medical technology companies seeking to establish and grow their presence in Italy. The company provides regulatory support, nationwide distribution, technical assistance, and local market expertise through a flexible operational model designed to simplify healthcare market entry and expansion.

References:

1. Data on File.